Global Recurrent Glioblastoma Multiforme Treatment Sales Market Report 2018

June 2018 | 113 pages | ID: G70D62F7486EN
QYResearch

Abstracts

This report studies the global Recurrent Glioblastoma Multiforme Treatment market status and forecast, categorizes the global Recurrent Glioblastoma Multiforme Treatment market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

The global Recurrent Glioblastoma Multiforme Treatment market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.
The major players covered in this report

• Boehringer Ingelheim GmbH
• Boston Biomedical, Inc.
• Bristol-Myers Squibb Company
• Cantex Pharmaceuticals, Inc.
• Cavion LLC
• Celldex Therapeutics, Inc.
• Coherus BioSciences, Inc.
• Cortice Biosciences, Inc.
• Eisai
• Eli Lilly and Company
• EnGeneIC Ltd
• ERC Belgium SA
• GenSpera, Inc.
• Genzyme Corporation
• GW Pharmaceuticals Plc
• ImmunoCellular Therapeutics, Ltd.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

• United States
• Europe
• China
• Japan
• Southeast Asia
• India

We can also provide the customized separate regional or country-level reports, for the following regions:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Singapore
• Rest of Asia-Pacific
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Central & South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• Turkey
• Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• AU-105
• Axitinib
• AXL-1717
• AZD-7451
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Others

The study objectives of this report are:

• To analyze and study the global Recurrent Glioblastoma Multiforme Treatment sales, value, status (2013-2017) and forecast (2018-2025);
• To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
• Focuses on the key Recurrent Glioblastoma Multiforme Treatment players, to study the sales, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Recurrent Glioblastoma Multiforme Treatment are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Recurrent Glioblastoma Multiforme Treatment Manufacturers
Recurrent Glioblastoma Multiforme Treatment Distributors/Traders/Wholesalers
Recurrent Glioblastoma Multiforme Treatment Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Recurrent Glioblastoma Multiforme Treatment market, by end-use.
Detailed analysis and profiles of additional market players.

Contents

Global Recurrent Glioblastoma Multiforme Treatment Sales Market Report 2018

1 RECURRENT GLIOBLASTOMA MULTIFORME TREATMENT MARKET OVERVIEW

1.1 Product Overview and Scope of Recurrent Glioblastoma Multiforme Treatment
1.2 Classification of Recurrent Glioblastoma Multiforme Treatment by Product Category
  1.2.1 Global Recurrent Glioblastoma Multiforme Treatment Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 Global Recurrent Glioblastoma Multiforme Treatment Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 AU-105
  1.2.4 Axitinib
  1.2.5 AXL-1717
  1.2.6 AZD-7451
  1.2.7 Others
1.3 Global Recurrent Glioblastoma Multiforme Treatment Market by Application/End Users
  1.3.1 Global Recurrent Glioblastoma Multiforme Treatment Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.1 Hospital
  1.3.2 Clinic
  1.3.3 Others
1.4 Global Recurrent Glioblastoma Multiforme Treatment Market by Region
  1.4.1 Global Recurrent Glioblastoma Multiforme Treatment Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 United States Recurrent Glioblastoma Multiforme Treatment Status and Prospect (2013-2025)
  1.4.3 Europe Recurrent Glioblastoma Multiforme Treatment Status and Prospect (2013-2025)
  1.4.4 China Recurrent Glioblastoma Multiforme Treatment Status and Prospect (2013-2025)
  1.4.5 Japan Recurrent Glioblastoma Multiforme Treatment Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Recurrent Glioblastoma Multiforme Treatment Status and Prospect (2013-2025)
  1.4.7 India Recurrent Glioblastoma Multiforme Treatment Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Recurrent Glioblastoma Multiforme Treatment (2013-2025)
  1.5.1 Global Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate (2013-2025)
  1.5.2 Global Recurrent Glioblastoma Multiforme Treatment Revenue and Growth Rate (2013-2025)

2 GLOBAL RECURRENT GLIOBLASTOMA MULTIFORME TREATMENT COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Recurrent Glioblastoma Multiforme Treatment Market Competition by Players/Suppliers
  2.1.1 Global Recurrent Glioblastoma Multiforme Treatment Sales and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Global Recurrent Glioblastoma Multiforme Treatment Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Recurrent Glioblastoma Multiforme Treatment (Volume and Value) by Type
  2.2.1 Global Recurrent Glioblastoma Multiforme Treatment Sales and Market Share by Type (2013-2018)
  2.2.2 Global Recurrent Glioblastoma Multiforme Treatment Revenue and Market Share by Type (2013-2018)
2.3 Global Recurrent Glioblastoma Multiforme Treatment (Volume and Value) by Region
  2.3.1 Global Recurrent Glioblastoma Multiforme Treatment Sales and Market Share by Region (2013-2018)
  2.3.2 Global Recurrent Glioblastoma Multiforme Treatment Revenue and Market Share by Region (2013-2018)
2.4 Global Recurrent Glioblastoma Multiforme Treatment (Volume) by Application

3 UNITED STATES RECURRENT GLIOBLASTOMA MULTIFORME TREATMENT (VOLUME, VALUE AND SALES PRICE)

3.1 United States Recurrent Glioblastoma Multiforme Treatment Sales and Value (2013-2018)
  3.1.1 United States Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate (2013-2018)
  3.1.2 United States Recurrent Glioblastoma Multiforme Treatment Revenue and Growth Rate (2013-2018)
  3.1.3 United States Recurrent Glioblastoma Multiforme Treatment Sales Price Trend (2013-2018)
3.2 United States Recurrent Glioblastoma Multiforme Treatment Sales Volume and Market Share by Players (2013-2018)
3.3 United States Recurrent Glioblastoma Multiforme Treatment Sales Volume and Market Share by Type (2013-2018)
3.4 United States Recurrent Glioblastoma Multiforme Treatment Sales Volume and Market Share by Application (2013-2018)

4 EUROPE RECURRENT GLIOBLASTOMA MULTIFORME TREATMENT (VOLUME, VALUE AND SALES PRICE)

4.1 Europe Recurrent Glioblastoma Multiforme Treatment Sales and Value (2013-2018)
  4.1.1 Europe Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate (2013-2018)
  4.1.2 Europe Recurrent Glioblastoma Multiforme Treatment Revenue and Growth Rate (2013-2018)
  4.1.3 Europe Recurrent Glioblastoma Multiforme Treatment Sales Price Trend (2013-2018)
4.2 Europe Recurrent Glioblastoma Multiforme Treatment Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Recurrent Glioblastoma Multiforme Treatment Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Recurrent Glioblastoma Multiforme Treatment Sales Volume and Market Share by Application (2013-2018)

5 CHINA RECURRENT GLIOBLASTOMA MULTIFORME TREATMENT (VOLUME, VALUE AND SALES PRICE)

5.1 China Recurrent Glioblastoma Multiforme Treatment Sales and Value (2013-2018)
  5.1.1 China Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate (2013-2018)
  5.1.2 China Recurrent Glioblastoma Multiforme Treatment Revenue and Growth Rate (2013-2018)
  5.1.3 China Recurrent Glioblastoma Multiforme Treatment Sales Price Trend (2013-2018)
5.2 China Recurrent Glioblastoma Multiforme Treatment Sales Volume and Market Share by Players (2013-2018)
5.3 China Recurrent Glioblastoma Multiforme Treatment Sales Volume and Market Share by Type (2013-2018)
5.4 China Recurrent Glioblastoma Multiforme Treatment Sales Volume and Market Share by Application (2013-2018)

6 JAPAN RECURRENT GLIOBLASTOMA MULTIFORME TREATMENT (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Recurrent Glioblastoma Multiforme Treatment Sales and Value (2013-2018)
  6.1.1 Japan Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate (2013-2018)
  6.1.2 Japan Recurrent Glioblastoma Multiforme Treatment Revenue and Growth Rate (2013-2018)
  6.1.3 Japan Recurrent Glioblastoma Multiforme Treatment Sales Price Trend (2013-2018)
6.2 Japan Recurrent Glioblastoma Multiforme Treatment Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Recurrent Glioblastoma Multiforme Treatment Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Recurrent Glioblastoma Multiforme Treatment Sales Volume and Market Share by Application (2013-2018)

7 SOUTHEAST ASIA RECURRENT GLIOBLASTOMA MULTIFORME TREATMENT (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Recurrent Glioblastoma Multiforme Treatment Sales and Value (2013-2018)
  7.1.1 Southeast Asia Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate (2013-2018)
  7.1.2 Southeast Asia Recurrent Glioblastoma Multiforme Treatment Revenue and Growth Rate (2013-2018)
  7.1.3 Southeast Asia Recurrent Glioblastoma Multiforme Treatment Sales Price Trend (2013-2018)
7.2 Southeast Asia Recurrent Glioblastoma Multiforme Treatment Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Recurrent Glioblastoma Multiforme Treatment Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Recurrent Glioblastoma Multiforme Treatment Sales Volume and Market Share by Application (2013-2018)

8 INDIA RECURRENT GLIOBLASTOMA MULTIFORME TREATMENT (VOLUME, VALUE AND SALES PRICE)

8.1 India Recurrent Glioblastoma Multiforme Treatment Sales and Value (2013-2018)
  8.1.1 India Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate (2013-2018)
  8.1.2 India Recurrent Glioblastoma Multiforme Treatment Revenue and Growth Rate (2013-2018)
  8.1.3 India Recurrent Glioblastoma Multiforme Treatment Sales Price Trend (2013-2018)
8.2 India Recurrent Glioblastoma Multiforme Treatment Sales Volume and Market Share by Players (2013-2018)
8.3 India Recurrent Glioblastoma Multiforme Treatment Sales Volume and Market Share by Type (2013-2018)
8.4 India Recurrent Glioblastoma Multiforme Treatment Sales Volume and Market Share by Application (2013-2018)

9 GLOBAL RECURRENT GLIOBLASTOMA MULTIFORME TREATMENT PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Boehringer Ingelheim GmbH
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Boehringer Ingelheim GmbH Recurrent Glioblastoma Multiforme Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  9.1.4 Main Business/Business Overview
9.2 Boston Biomedical, Inc.
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Boston Biomedical, Inc. Recurrent Glioblastoma Multiforme Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  9.2.4 Main Business/Business Overview
9.3 Bristol-Myers Squibb Company
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Bristol-Myers Squibb Company Recurrent Glioblastoma Multiforme Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  9.3.4 Main Business/Business Overview
9.4 Cantex Pharmaceuticals, Inc.
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Cantex Pharmaceuticals, Inc. Recurrent Glioblastoma Multiforme Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  9.4.4 Main Business/Business Overview
9.5 Cavion LLC
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Cavion LLC Recurrent Glioblastoma Multiforme Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  9.5.4 Main Business/Business Overview
9.6 Celldex Therapeutics, Inc.
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Celldex Therapeutics, Inc. Recurrent Glioblastoma Multiforme Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  9.6.4 Main Business/Business Overview
9.7 Coherus BioSciences, Inc.
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Coherus BioSciences, Inc. Recurrent Glioblastoma Multiforme Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  9.7.4 Main Business/Business Overview
9.8 Cortice Biosciences, Inc.
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Cortice Biosciences, Inc. Recurrent Glioblastoma Multiforme Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  9.8.4 Main Business/Business Overview
9.9 Eisai
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Eisai Recurrent Glioblastoma Multiforme Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  9.9.4 Main Business/Business Overview
9.10 Eli Lilly and Company
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Eli Lilly and Company Recurrent Glioblastoma Multiforme Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  9.10.4 Main Business/Business Overview
9.11 EnGeneIC Ltd
9.12 ERC Belgium SA
9.13 GenSpera, Inc.
9.14 Genzyme Corporation
9.15 GW Pharmaceuticals Plc
9.16 ImmunoCellular Therapeutics, Ltd.

10 RECURRENT GLIOBLASTOMA MULTIFORME TREATMENT MAUFACTURING COST ANALYSIS

10.1 Recurrent Glioblastoma Multiforme Treatment Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Recurrent Glioblastoma Multiforme Treatment
10.3 Manufacturing Process Analysis of Recurrent Glioblastoma Multiforme Treatment

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Recurrent Glioblastoma Multiforme Treatment Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Recurrent Glioblastoma Multiforme Treatment Major Manufacturers in 2017
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL RECURRENT GLIOBLASTOMA MULTIFORME TREATMENT MARKET FORECAST (2018-2025)

14.1 Global Recurrent Glioblastoma Multiforme Treatment Sales Volume, Revenue and Price Forecast (2018-2025)
  14.1.1 Global Recurrent Glioblastoma Multiforme Treatment Sales Volume and Growth Rate Forecast (2018-2025)
  14.1.2 Global Recurrent Glioblastoma Multiforme Treatment Revenue and Growth Rate Forecast (2018-2025)
  14.1.3 Global Recurrent Glioblastoma Multiforme Treatment Price and Trend Forecast (2018-2025)
14.2 Global Recurrent Glioblastoma Multiforme Treatment Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  14.2.1 Global Recurrent Glioblastoma Multiforme Treatment Sales Volume and Growth Rate Forecast by Regions (2018-2025)
  14.2.2 Global Recurrent Glioblastoma Multiforme Treatment Revenue and Growth Rate Forecast by Regions (2018-2025)
  14.2.3 United States Recurrent Glioblastoma Multiforme Treatment Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.4 Europe Recurrent Glioblastoma Multiforme Treatment Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.5 China Recurrent Glioblastoma Multiforme Treatment Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.6 Japan Recurrent Glioblastoma Multiforme Treatment Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.7 Southeast Asia Recurrent Glioblastoma Multiforme Treatment Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.8 India Recurrent Glioblastoma Multiforme Treatment Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Recurrent Glioblastoma Multiforme Treatment Sales Volume, Revenue and Price Forecast by Type (2018-2025)
  14.3.1 Global Recurrent Glioblastoma Multiforme Treatment Sales Forecast by Type (2018-2025)
  14.3.2 Global Recurrent Glioblastoma Multiforme Treatment Revenue Forecast by Type (2018-2025)
  14.3.3 Global Recurrent Glioblastoma Multiforme Treatment Price Forecast by Type (2018-2025)
14.4 Global Recurrent Glioblastoma Multiforme Treatment Sales Volume Forecast by Application (2018-2025)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES
Figure Product Picture of Recurrent Glioblastoma Multiforme Treatment
Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Volume Comparison (K Pcs) by Type (2013-2025)
Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Type (Product Category) in 2017
Figure AU-105 Product Picture
Figure Axitinib Product Picture
Figure AXL-1717 Product Picture
Figure AZD-7451 Product Picture
Figure Others Product Picture
Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Comparison (K Pcs) by Application (2013-2025)
Figure Global Sales Market Share of Recurrent Glioblastoma Multiforme Treatment by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Recurrent Glioblastoma Multiforme Treatment Market Size (Million USD) by Regions (2013-2025)
Figure United States Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) and Growth Rate (2013-2025)
Figure Global Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) (2013-2018)
Table Global Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table Global Recurrent Glioblastoma Multiforme Treatment Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Recurrent Glioblastoma Multiforme Treatment Sales Share by Players/Suppliers
Figure 2017 Recurrent Glioblastoma Multiforme Treatment Sales Share by Players/Suppliers
Figure Global Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Recurrent Glioblastoma Multiforme Treatment Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Recurrent Glioblastoma Multiforme Treatment Revenue Share by Players
Table 2017 Global Recurrent Glioblastoma Multiforme Treatment Revenue Share by Players
Table Global Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Market Share by Type (2013-2018)
Table Global Recurrent Glioblastoma Multiforme Treatment Sales Share (K Pcs) by Type (2013-2018)
Figure Sales Market Share of Recurrent Glioblastoma Multiforme Treatment by Type (2013-2018)
Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Growth Rate by Type (2013-2018)
Table Global Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Recurrent Glioblastoma Multiforme Treatment Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Recurrent Glioblastoma Multiforme Treatment by Type (2013-2018)
Figure Global Recurrent Glioblastoma Multiforme Treatment Revenue Growth Rate by Type (2013-2018)
Table Global Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) and Market Share by Region (2013-2018)
Table Global Recurrent Glioblastoma Multiforme Treatment Sales Share by Region (2013-2018)
Figure Sales Market Share of Recurrent Glioblastoma Multiforme Treatment by Region (2013-2018)
Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Growth Rate by Region in 2017
Table Global Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Recurrent Glioblastoma Multiforme Treatment Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Recurrent Glioblastoma Multiforme Treatment by Region (2013-2018)
Figure Global Recurrent Glioblastoma Multiforme Treatment Revenue Growth Rate by Region in 2017
Table Global Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Recurrent Glioblastoma Multiforme Treatment Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Recurrent Glioblastoma Multiforme Treatment by Region (2013-2018)
Figure Global Recurrent Glioblastoma Multiforme Treatment Revenue Market Share by Region in 2017
Table Global Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) and Market Share by Application (2013-2018)
Table Global Recurrent Glioblastoma Multiforme Treatment Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Recurrent Glioblastoma Multiforme Treatment by Application (2013-2018)
Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Market Share by Application (2013-2018)
Figure United States Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure United States Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Recurrent Glioblastoma Multiforme Treatment Sales Price (USD/Pcs) Trend (2013-2018)
Table United States Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) by Players (2013-2018)
Table United States Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Players (2013-2018)
Figure United States Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Players in 2017
Table United States Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) by Type (2013-2018)
Table United States Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Type (2013-2018)
Figure United States Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Type in 2017
Table United States Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) by Application (2013-2018)
Table United States Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Application (2013-2018)
Figure United States Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Application in 2017
Figure Europe Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Recurrent Glioblastoma Multiforme Treatment Sales Price (USD/Pcs) Trend (2013-2018)
Table Europe Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) by Players (2013-2018)
Table Europe Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Players (2013-2018)
Figure Europe Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Players in 2017
Table Europe Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) by Type (2013-2018)
Table Europe Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Type (2013-2018)
Figure Europe Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Type in 2017
Table Europe Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) by Application (2013-2018)
Table Europe Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Application (2013-2018)
Figure Europe Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Application in 2017
Figure China Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure China Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Recurrent Glioblastoma Multiforme Treatment Sales Price (USD/Pcs) Trend (2013-2018)
Table China Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) by Players (2013-2018)
Table China Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Players (2013-2018)
Figure China Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Players in 2017
Table China Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) by Type (2013-2018)
Table China Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Type (2013-2018)
Figure China Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Type in 2017
Table China Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) by Application (2013-2018)
Table China Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Application (2013-2018)
Figure China Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Application in 2017
Figure Japan Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Japan Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Recurrent Glioblastoma Multiforme Treatment Sales Price (USD/Pcs) Trend (2013-2018)
Table Japan Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) by Players (2013-2018)
Table Japan Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Players (2013-2018)
Figure Japan Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Players in 2017
Table Japan Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) by Type (2013-2018)
Table Japan Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Type (2013-2018)
Figure Japan Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Type in 2017
Table Japan Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) by Application (2013-2018)
Table Japan Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Application (2013-2018)
Figure Japan Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Application in 2017
Figure Southeast Asia Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Southeast Asia Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Recurrent Glioblastoma Multiforme Treatment Sales Price (USD/Pcs) Trend (2013-2018)
Table Southeast Asia Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) by Players (2013-2018)
Table Southeast Asia Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Players in 2017
Table Southeast Asia Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) by Type (2013-2018)
Table Southeast Asia Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Type in 2017
Table Southeast Asia Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) by Application (2013-2018)
Table Southeast Asia Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Application in 2017
Figure India Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure India Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Recurrent Glioblastoma Multiforme Treatment Sales Price (USD/Pcs) Trend (2013-2018)
Table India Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) by Players (2013-2018)
Table India Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Players (2013-2018)
Figure India Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Players in 2017
Table India Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) by Type (2013-2018)
Table India Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Type (2013-2018)
Figure India Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Type in 2017
Table India Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) by Application (2013-2018)
Table India Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Application (2013-2018)
Figure India Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share by Application in 2017
Table Boehringer Ingelheim GmbH Basic Information List
Table Boehringer Ingelheim GmbH Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim GmbH Recurrent Glioblastoma Multiforme Treatment Sales Growth Rate (2013-2018)
Figure Boehringer Ingelheim GmbH Recurrent Glioblastoma Multiforme Treatment Sales Global Market Share (2013-2018)
Figure Boehringer Ingelheim GmbH Recurrent Glioblastoma Multiforme Treatment Revenue Global Market Share (2013-2018)
Table Boston Biomedical, Inc. Basic Information List
Table Boston Biomedical, Inc. Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Boston Biomedical, Inc. Recurrent Glioblastoma Multiforme Treatment Sales Growth Rate (2013-2018)
Figure Boston Biomedical, Inc. Recurrent Glioblastoma Multiforme Treatment Sales Global Market Share (2013-2018)
Figure Boston Biomedical, Inc. Recurrent Glioblastoma Multiforme Treatment Revenue Global Market Share (2013-2018)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Company Recurrent Glioblastoma Multiforme Treatment Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Company Recurrent Glioblastoma Multiforme Treatment Sales Global Market Share (2013-2018
Figure Bristol-Myers Squibb Company Recurrent Glioblastoma Multiforme Treatment Revenue Global Market Share (2013-2018)
Table Cantex Pharmaceuticals, Inc. Basic Information List
Table Cantex Pharmaceuticals, Inc. Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Cantex Pharmaceuticals, Inc. Recurrent Glioblastoma Multiforme Treatment Sales Growth Rate (2013-2018)
Figure Cantex Pharmaceuticals, Inc. Recurrent Glioblastoma Multiforme Treatment Sales Global Market Share (2013-2018)
Figure Cantex Pharmaceuticals, Inc. Recurrent Glioblastoma Multiforme Treatment Revenue Global Market Share (2013-2018)
Table Cavion LLC Basic Information List
Table Cavion LLC Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Cavion LLC Recurrent Glioblastoma Multiforme Treatment Sales Growth Rate (2013-2018)
Figure Cavion LLC Recurrent Glioblastoma Multiforme Treatment Sales Global Market Share (2013-2018)
Figure Cavion LLC Recurrent Glioblastoma Multiforme Treatment Revenue Global Market Share (2013-2018)
Table Celldex Therapeutics, Inc. Basic Information List
Table Celldex Therapeutics, Inc. Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Celldex Therapeutics, Inc. Recurrent Glioblastoma Multiforme Treatment Sales Growth Rate (2013-2018)
Figure Celldex Therapeutics, Inc. Recurrent Glioblastoma Multiforme Treatment Sales Global Market Share (2013-2018
Figure Celldex Therapeutics, Inc. Recurrent Glioblastoma Multiforme Treatment Revenue Global Market Share (2013-2018)
Table Coherus BioSciences, Inc. Basic Information List
Table Coherus BioSciences, Inc. Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Coherus BioSciences, Inc. Recurrent Glioblastoma Multiforme Treatment Sales Growth Rate (2013-2018)
Figure Coherus BioSciences, Inc. Recurrent Glioblastoma Multiforme Treatment Sales Global Market Share (2013-2018)
Figure Coherus BioSciences, Inc. Recurrent Glioblastoma Multiforme Treatment Revenue Global Market Share (2013-2018)
Table Cortice Biosciences, Inc. Basic Information List
Table Cortice Biosciences, Inc. Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Cortice Biosciences, Inc. Recurrent Glioblastoma Multiforme Treatment Sales Growth Rate (2013-2018)
Figure Cortice Biosciences, Inc. Recurrent Glioblastoma Multiforme Treatment Sales Global Market Share (2013-2018
Figure Cortice Biosciences, Inc. Recurrent Glioblastoma Multiforme Treatment Revenue Global Market Share (2013-2018)
Table Eisai Basic Information List
Table Eisai Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Eisai Recurrent Glioblastoma Multiforme Treatment Sales Growth Rate (2013-2018)
Figure Eisai Recurrent Glioblastoma Multiforme Treatment Sales Global Market Share (2013-2018)
Figure Eisai Recurrent Glioblastoma Multiforme Treatment Revenue Global Market Share (2013-2018)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Eli Lilly and Company Recurrent Glioblastoma Multiforme Treatment Sales Growth Rate (2013-2018)
Figure Eli Lilly and Company Recurrent Glioblastoma Multiforme Treatment Sales Global Market Share (2013-2018)
Figure Eli Lilly and Company Recurrent Glioblastoma Multiforme Treatment Revenue Global Market Share (2013-2018)
Table EnGeneIC Ltd Basic Information List
Table ERC Belgium SA Basic Information List
Table GenSpera, Inc. Basic Information List
Table Genzyme Corporation Basic Information List
Table GW Pharmaceuticals Plc Basic Information List
Table ImmunoCellular Therapeutics, Ltd. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recurrent Glioblastoma Multiforme Treatment
Figure Manufacturing Process Analysis of Recurrent Glioblastoma Multiforme Treatment
Figure Recurrent Glioblastoma Multiforme Treatment Industrial Chain Analysis
Table Raw Materials Sources of Recurrent Glioblastoma Multiforme Treatment Major Players in 2017
Table Major Buyers of Recurrent Glioblastoma Multiforme Treatment
Table Distributors/Traders List
Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Recurrent Glioblastoma Multiforme Treatment Price (USD/Pcs) and Trend Forecast (2018-2025)
Table Global Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) Forecast by Regions (2018-2025)
Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share Forecast by Regions in 2025
Table Global Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Recurrent Glioblastoma Multiforme Treatment Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Recurrent Glioblastoma Multiforme Treatment Revenue Market Share Forecast by Regions in 2025
Figure United States Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Recurrent Glioblastoma Multiforme Treatment Revenue and Growth Rate Forecast (2018-2025)
Figure China Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Recurrent Glioblastoma Multiforme Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) Forecast by Type (2018-2025)
Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Recurrent Glioblastoma Multiforme Treatment Revenue Market Share Forecast by Type (2018-2025)
Table Global Recurrent Glioblastoma Multiforme Treatment Price (USD/Pcs) Forecast by Type (2018-2025)
Table Global Recurrent Glioblastoma Multiforme Treatment Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources